Literature DB >> 7008640

Immunotherapy in hay fever with two major allergens 19, 25 and partially purified extract of timothy grass pollen. A controlled double blind study. In vivo variables, season I.

O Osterballe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7008640     DOI： 10.1111/j.1398-9995.1980.tb01795.x

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  5 in total

Review 1.  Allergen injection immunotherapy for seasonal allergic rhinitis.

Authors:  M A Calderon; B Alves; M Jacobson; B Hurwitz; A Sheikh; S Durham
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 2.  Recombinant allergens/allergen standardization.

Authors:  H Løwenstein; J N Larsen
Journal:  Curr Allergy Asthma Rep       Date:  2001-09       Impact factor: 4.806

Review 3.  Safety considerations in assessing the role of immunotherapy in allergic disorders.

Authors:  J Bousquet; F B Michel
Journal:  Drug Saf       Date:  1994-01       Impact factor: 5.606

4.  Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs.

Authors:  V A Varney; M Gaga; A J Frew; V R Aber; A B Kay; S R Durham
Journal:  BMJ       Date:  1991-02-02

Review 5.  Allergen Immunotherapy: Biomarkers and Clinical Outcome Measures.

Authors:  Constantinos Pitsios
Journal:  J Asthma Allergy       Date:  2021-02-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.